Experienced Healthcare Technology Executive Positions Company to Transform Rapidly Evolving Industry
Whitehurst brings strong commercial experience and go-to-market strategy expertise to his new role, making him an ideal fit for Health Fidelity, which is scaling up after successfully proving its technology’s ability to streamline risk adjustment operations, achieve higher levels of compliance and realize greater efficiencies at one of the country’s largest and most innovative health systems, the University of Pittsburgh Medical Center (UPMC) health system. UPMC made a significant investment in Health Fidelity after seeing the value it delivers first-hand. At this critical juncture, Whitehurst, who also has extensive experience with funding and investment structures and often serves as a board member and mentor in the healthcare technology community, will more broadly commercialize and scale the business.
“Health Fidelity has the potential to make a huge impact in the healthcare industry,” said Whitehurst. “We have an excellent team in place, and I’m incredibly excited about working with my colleagues and our partners to fundamentally change the industry with technology that enables more efficient and effective population health management.”
Before he joined Health Fidelity, Whitehurst served as SVP and GM of Stericycle, where he successfully scaled the company for an emerging market, improving top-line and profitability through organic and acquisition growth. Whitehurst joined Stericycle via the acquisition of BerylHealth, where he served as SVP and Chief Strategist. He was recruited to spearhead development of a business transformation and go-to-market strategy for BerylHealth, where he built strong commercial and operational scale to achieve a strategic exit after doubling valuation in just two years.
Whitehurst also served as EVP and Executive Managing Director of H5 Inc., the leading technology-assisted information retrieval and data analytics service provider in the legal sector. This experience is directly relevant to his new role as Health Fidelity CEO since Health Fidelity applies cutting-edge NLP technology to maximize client value with continuous risk adjustment cycle improvement. At H5, Whitehurst worked with the venture capital-backed board to accelerate the commercialization and position the company for rapid growth. Prior to that, he served as SVP and GM at McKesson Corporation, a Fortune 20 company and leading healthcare technology innovator, where he led several key development, new market expansion and revenue growth initiatives in the laboratory, life sciences and automation space.
“Steve is a perfect fit for Health Fidelity because he’s a dedicated team-builder and has a proven track record of identifying new market and customer requirements and positioning healthcare tech companies to meet them,” said Anand Shroff, co-founder, Chief Technology Officer and Product Officer at Health Fidelity. “We’re thrilled to have a CEO of Steve’s caliber leading the company as we accelerate introduction of the Health Fidelity solution to market and innovate on additional use cases.”
Health Fidelity provides critical insights to assist organizations that are making population management decisions. Today, most organizations are able to use only 20% to 30% of available information because of the challenges involved in interpreting and applying unstructured data. Health Fidelity allows integrated delivery systems, health plans and health systems to leverage all available data to streamline risk adjustment operations, achieve higher levels of compliance and realize greater efficiencies. To learn more about Health Fidelity and its groundbreaking value-based care solutions, please visit www.healthfidelity.com.